series-a
Stage
1
Investors
About
Tenboron is a clinical stage biopharmaceutical company developing novel boron carriers for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiotherapy that selectively destroys cancer cells while sparing healthy tissue.
Explore Tenboron's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.